Skip to search formSkip to main contentSkip to account menu

ETC-588

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

1-oleoyl-2-palmitoylphosphatidylcholine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
ETC-588 (Pfizer).
Pfizer, following its acquisition of Esperion Therapeutics in the first quarter of 2004, is developing ETC-588 as a potential… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)